Page last updated: 2024-10-30

metformin and Skin Ulcer

metformin has been researched along with Skin Ulcer in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Skin Ulcer: An ULCER of the skin and underlying tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Tawfeek, HM1
Abou-Taleb, DAE1
Badary, DM1
Ibrahim, M1
Abdellatif, AAH1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata: a Clinical and Dermoscopic Study.[NCT06087796]Phase 160 participants (Anticipated)Interventional2023-10-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for metformin and Skin Ulcer

ArticleYear
Pharmaceutical, clinical, and immunohistochemical studies of metformin hydrochloride topical hydrogel for wound healing application.
    Archives of dermatological research, 2020, Volume: 312, Issue:2

    Topics: Administration, Topical; Animals; Female; Humans; Hydrogels; Hypoglycemic Agents; Male; Metformin; P

2020